Skip to main content
Erschienen in: Prevention Science 4/2011

01.12.2011

Conceptual Framework for Standard Economic Evaluation of Physical Activity Programs in Primary Prevention

verfasst von: Silke B. Wolfenstetter

Erschienen in: Prevention Science | Ausgabe 4/2011

Einloggen, um Zugang zu erhalten

Abstract

Economic evaluations of primary prevention physical activity programs have gained importance because of scarce resources in health-care-systems. A concept for economic evaluation should be based on the efficacy of physical activity, the standard methods of economic evaluation and the aims of public health. Previous publications have examined only parts of these components and have not developed a comprehensive conceptual framework; it is the objective of this article to develop such a framework. The derived method should aid decision makers and staff members of intervention programs in reviewing and conducting an economic evaluation. A literature search of articles was done using six electronic databases. Referenced works for standard methods and more comprehensive approaches for evaluation of preventive programs were studied. The newly developed conceptual framework for economic evaluation includes: (1) the type of physical activity program; (2) features of a selected study population; (3) the outcome dimension comprising exercise efficacy, reach, recruitment, response rate, maintenance, compliance and adverse health effects plus the social impact; and (4) the cost dimension consisting of program development costs, program implementation costs including the implementation, recruitment, program, participants’ time costs and savings resulting from the health effects of the intervention. Cost-effectiveness also depends on the methodology, such as the chosen perspective, data collection, valuation methods and discounting. If an intervention is not considered cost-effective, it is necessary to check each dimension to find possible failures in order to learn for future interventions. A more detailed economic evaluation is of utmost importance for improved comparability and transferability.
Literatur
Zurück zum Zitat Ackermann, R. T., Cheadle, A., Sandhu, N., Madsen, L., Wagner, E. H., & LoGerfo, J. P. (2003). Community exercise program use and changes in healthcare costs for older adults. American Journal of Preventive Medicine, 25, 232–237.PubMedCrossRef Ackermann, R. T., Cheadle, A., Sandhu, N., Madsen, L., Wagner, E. H., & LoGerfo, J. P. (2003). Community exercise program use and changes in healthcare costs for older adults. American Journal of Preventive Medicine, 25, 232–237.PubMedCrossRef
Zurück zum Zitat Andersen, R. M. (1995). Revisiting the behavioral model and access to medical care: Does it matter? Journal of Health and Social Behavior, 36, 1–10.PubMedCrossRef Andersen, R. M. (1995). Revisiting the behavioral model and access to medical care: Does it matter? Journal of Health and Social Behavior, 36, 1–10.PubMedCrossRef
Zurück zum Zitat Anis, A. H., & Gagnon, Y. (2000). Using economic evaluations to make formulary coverage decisions: So much for guidelines. Pharmacoeconomics, 18, 55–62.PubMedCrossRef Anis, A. H., & Gagnon, Y. (2000). Using economic evaluations to make formulary coverage decisions: So much for guidelines. Pharmacoeconomics, 18, 55–62.PubMedCrossRef
Zurück zum Zitat Antonanzas, F. (2004). Transferability of economic evaluation results. Pharmacoeconomics, 22, 827.PubMedCrossRef Antonanzas, F. (2004). Transferability of economic evaluation results. Pharmacoeconomics, 22, 827.PubMedCrossRef
Zurück zum Zitat Baltussen, R., Leidl, R., & Ament, A. (1999). Real world designs in economic evaluation. Bridging the gap between clinical research and policy-making. Pharmacoeconomics, 16, 449–458.PubMedCrossRef Baltussen, R., Leidl, R., & Ament, A. (1999). Real world designs in economic evaluation. Bridging the gap between clinical research and policy-making. Pharmacoeconomics, 16, 449–458.PubMedCrossRef
Zurück zum Zitat Bleichrodt, H. (2002). A new explanation for the difference between time trade-off utilities and standard gamble utilities. Health Economics, 11, 447–456.PubMedCrossRef Bleichrodt, H. (2002). A new explanation for the difference between time trade-off utilities and standard gamble utilities. Health Economics, 11, 447–456.PubMedCrossRef
Zurück zum Zitat Bleichrodt, H., & Johannesson, M. (1997). Standard gamble, time trade-off and rating scale: Experimental results on the ranking properties of QALYs. Journal of Health Economics, 16, 155–175.PubMedCrossRef Bleichrodt, H., & Johannesson, M. (1997). Standard gamble, time trade-off and rating scale: Experimental results on the ranking properties of QALYs. Journal of Health Economics, 16, 155–175.PubMedCrossRef
Zurück zum Zitat Boulenger, S., Nixon, J., Drummond, M., Ulmann, P., Rice, S., & de Pouvourville, G. (2005). Can economic evaluations be made more transferable? The European Journal of Health Economics, 6, 334–346.PubMedCrossRef Boulenger, S., Nixon, J., Drummond, M., Ulmann, P., Rice, S., & de Pouvourville, G. (2005). Can economic evaluations be made more transferable? The European Journal of Health Economics, 6, 334–346.PubMedCrossRef
Zurück zum Zitat Bradley, E. H., McGraw, S. A., Curry, L., Buckser, A., King, K. L., Kasl, S. V., et al. (2002). Expanding the Andersen model: The role of psychosocial factors in long-term care use. Health Services Research, 37, 1221–1242.PubMedCrossRef Bradley, E. H., McGraw, S. A., Curry, L., Buckser, A., King, K. L., Kasl, S. V., et al. (2002). Expanding the Andersen model: The role of psychosocial factors in long-term care use. Health Services Research, 37, 1221–1242.PubMedCrossRef
Zurück zum Zitat Brazier, J. E., & Roberts, J. (2004). The estimation of a preference-based measure of health from the SF-12. Medical Care, 42, 851–859.PubMedCrossRef Brazier, J. E., & Roberts, J. (2004). The estimation of a preference-based measure of health from the SF-12. Medical Care, 42, 851–859.PubMedCrossRef
Zurück zum Zitat Brazier, J. E., Harper, R., Jones, N. M., O’Cathain, A., Thomas, K. J., Usherwood, T., et al. (1992). Validating the SF-36 health survey questionnaire: New outcome measure for primary care. British Medical Journal, 305, 160–164.PubMedCrossRef Brazier, J. E., Harper, R., Jones, N. M., O’Cathain, A., Thomas, K. J., Usherwood, T., et al. (1992). Validating the SF-36 health survey questionnaire: New outcome measure for primary care. British Medical Journal, 305, 160–164.PubMedCrossRef
Zurück zum Zitat Brazier, J., Roberts, J., & Deverill, M. (2002). The estimation of a preference-based measure of health from the SF-36. Journal of Health Economics, 21, 271–292.PubMedCrossRef Brazier, J., Roberts, J., & Deverill, M. (2002). The estimation of a preference-based measure of health from the SF-36. Journal of Health Economics, 21, 271–292.PubMedCrossRef
Zurück zum Zitat Brouwer, W., Rutten, F., & Koopmanschap, M. (2001). Costing in economic evaluations. In M. F. Drummond & A. McGuire (Eds.), Economic evaluations in health care: Merging theory with practice. New York: Oxford University Press. Brouwer, W., Rutten, F., & Koopmanschap, M. (2001). Costing in economic evaluations. In M. F. Drummond & A. McGuire (Eds.), Economic evaluations in health care: Merging theory with practice. New York: Oxford University Press.
Zurück zum Zitat Campbell, A. J., Robertson, M. C., La Grow, S. J., Kerse, N. M., Sanderson, G. F., Jacobs, R. J., et al. (2005). Randomised controlled trial of prevention of falls in people aged > or =75 with severe visual impairment: The VIP trial. British Medical Journal, 331, 817.PubMedCrossRef Campbell, A. J., Robertson, M. C., La Grow, S. J., Kerse, N. M., Sanderson, G. F., Jacobs, R. J., et al. (2005). Randomised controlled trial of prevention of falls in people aged > or =75 with severe visual impairment: The VIP trial. British Medical Journal, 331, 817.PubMedCrossRef
Zurück zum Zitat Cohen, D. (1994). Health promotion and cost-effectiveness. Health Promotion International, 9, 281–287.CrossRef Cohen, D. (1994). Health promotion and cost-effectiveness. Health Promotion International, 9, 281–287.CrossRef
Zurück zum Zitat Department of Health. (2004). At least five a week; evidence on the impact of physical activity and its relationship to health. A report from the Chief Medical Officer. London, UK: Department of Health. Department of Health. (2004). At least five a week; evidence on the impact of physical activity and its relationship to health. A report from the Chief Medical Officer. London, UK: Department of Health.
Zurück zum Zitat Drummond, M. F., & Jefferson, T. O. (1996). Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party. British Medical Journal, 313, 275–283.PubMedCrossRef Drummond, M. F., & Jefferson, T. O. (1996). Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party. British Medical Journal, 313, 275–283.PubMedCrossRef
Zurück zum Zitat Drummond, M., Manca, A., & Sculpher, M. (2005). Increasing the generalizability of economic evaluations: Recommendations for the design, analysis, and reporting of studies. International Journal of Technology Assessment in Health Care, 21, 165–171.PubMed Drummond, M., Manca, A., & Sculpher, M. (2005). Increasing the generalizability of economic evaluations: Recommendations for the design, analysis, and reporting of studies. International Journal of Technology Assessment in Health Care, 21, 165–171.PubMed
Zurück zum Zitat Drummond, M. F., Sculpher, M., Torrance, G. W., O’Brien, B. J., & Stoddart, G. L. (2005). Methods for economic evaluation of health care programs. New York: Oxford University Press. Drummond, M. F., Sculpher, M., Torrance, G. W., O’Brien, B. J., & Stoddart, G. L. (2005). Methods for economic evaluation of health care programs. New York: Oxford University Press.
Zurück zum Zitat Dzewaltowski, D. A., Glasgow, R. E., Klesges, L. M., Estabrooks, P. A., & Brock, E. (2004). RE-AIM: Evidence-based standards and a Web resource to improve translation of research into practice. Annals of Behavioral Medicine, 28, 75–80.PubMedCrossRef Dzewaltowski, D. A., Glasgow, R. E., Klesges, L. M., Estabrooks, P. A., & Brock, E. (2004). RE-AIM: Evidence-based standards and a Web resource to improve translation of research into practice. Annals of Behavioral Medicine, 28, 75–80.PubMedCrossRef
Zurück zum Zitat Ellert, U., & Kurth, B. M. (2004). Methodological views on the SF-36 summary scores based on the adult German population [in German]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, 47, 1027–1032.PubMedCrossRef Ellert, U., & Kurth, B. M. (2004). Methodological views on the SF-36 summary scores based on the adult German population [in German]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, 47, 1027–1032.PubMedCrossRef
Zurück zum Zitat Fuchs, R. (2003). Sport, Gesundheit und Public Health [in German]. Göttingen, Germany: Hogrefe. Fuchs, R. (2003). Sport, Gesundheit und Public Health [in German]. Göttingen, Germany: Hogrefe.
Zurück zum Zitat Furlong, W. J., Feeny, D. H., Torrance, G. W., & Barr, R. D. (2001). The Health Utilities Index (HUI) system for assessing health-related quality of life in clinical studies. Annals of Medicine, 33, 375–384.PubMedCrossRef Furlong, W. J., Feeny, D. H., Torrance, G. W., & Barr, R. D. (2001). The Health Utilities Index (HUI) system for assessing health-related quality of life in clinical studies. Annals of Medicine, 33, 375–384.PubMedCrossRef
Zurück zum Zitat Glasgow, R. E., Vogt, T. M., & Boles, S. M. (1999). Evaluating the public health impact of health promotion interventions: The RE-AIM framework. American Journal of Public Health, 89, 1322–1327.PubMedCrossRef Glasgow, R. E., Vogt, T. M., & Boles, S. M. (1999). Evaluating the public health impact of health promotion interventions: The RE-AIM framework. American Journal of Public Health, 89, 1322–1327.PubMedCrossRef
Zurück zum Zitat Goeree, R., Burke, N., O’Reilly, D., Manca, A., Blackhouse, G., & Tarride, J. E. (2007). Transferability of economic evaluations: Approaches and factors to consider when using results from one geographic area for another. Current Medical Research and Opinion, 23, 671–682.PubMedCrossRef Goeree, R., Burke, N., O’Reilly, D., Manca, A., Blackhouse, G., & Tarride, J. E. (2007). Transferability of economic evaluations: Approaches and factors to consider when using results from one geographic area for another. Current Medical Research and Opinion, 23, 671–682.PubMedCrossRef
Zurück zum Zitat Gold, M. R., Russell, L. B., & Siegel, J. E. (1996). Cost-effectiveness in health and medicine. New York: Oxford University Press. Gold, M. R., Russell, L. B., & Siegel, J. E. (1996). Cost-effectiveness in health and medicine. New York: Oxford University Press.
Zurück zum Zitat Graf von der Schulenburg, J. M., Greiner, W., Jost, F., Klusen, N., Kubin, M., Leidl, R., et al. (2008). German recommendations on health economic evaluation: Third and updated version of the Hanover Consensus. Value Health, 11, 539–544.PubMedCrossRef Graf von der Schulenburg, J. M., Greiner, W., Jost, F., Klusen, N., Kubin, M., Leidl, R., et al. (2008). German recommendations on health economic evaluation: Third and updated version of the Hanover Consensus. Value Health, 11, 539–544.PubMedCrossRef
Zurück zum Zitat Green, L. W. (1980). Current report: Office of health information, health promotion, physical fitness and sports medicine. Health Education, 11, 28.PubMed Green, L. W. (1980). Current report: Office of health information, health promotion, physical fitness and sports medicine. Health Education, 11, 28.PubMed
Zurück zum Zitat Green, L. W., & Iverson, D. C. (1982). School health education. Annual Review of Public Health, 3, 321–338.PubMedCrossRef Green, L. W., & Iverson, D. C. (1982). School health education. Annual Review of Public Health, 3, 321–338.PubMedCrossRef
Zurück zum Zitat Greiner, W., Weijnen, T., Nieuwenhuizen, M., Oppe, S., Badia, X., Busschbach, J., et al. (2003). A single European currency for EQ-5D health states. Results from a six-country study. The European Journal of Health Economics, 4, 222–231.PubMedCrossRef Greiner, W., Weijnen, T., Nieuwenhuizen, M., Oppe, S., Badia, X., Busschbach, J., et al. (2003). A single European currency for EQ-5D health states. Results from a six-country study. The European Journal of Health Economics, 4, 222–231.PubMedCrossRef
Zurück zum Zitat Hagberg, L. A., & Lindholm, L. (2005). Is promotion of physical activity a wise use of societal resources? Issues of cost-effectiveness and equity in health. Scandinavian Journal of Medicine and Science in Sports, 15, 304–312.PubMedCrossRef Hagberg, L. A., & Lindholm, L. (2005). Is promotion of physical activity a wise use of societal resources? Issues of cost-effectiveness and equity in health. Scandinavian Journal of Medicine and Science in Sports, 15, 304–312.PubMedCrossRef
Zurück zum Zitat Hawthorne, G., Richardson, J., & Osborne, R. (1999). The Assessment of Quality of Life (AQoL) instrument: A psychometric measure of health-related quality of life. Quality of Life Research, 8, 209–224.PubMedCrossRef Hawthorne, G., Richardson, J., & Osborne, R. (1999). The Assessment of Quality of Life (AQoL) instrument: A psychometric measure of health-related quality of life. Quality of Life Research, 8, 209–224.PubMedCrossRef
Zurück zum Zitat Haycox, A. (1994). A methodology for estimating the costs and benefits of health promotion. Health Promotion International, 9, 5–11.CrossRef Haycox, A. (1994). A methodology for estimating the costs and benefits of health promotion. Health Promotion International, 9, 5–11.CrossRef
Zurück zum Zitat Henry, D. A. (1992). The Australian Guidelines for subsidisation of pharmaceuticals. Pharmacoeconomics, 2, 422–426.PubMedCrossRef Henry, D. A. (1992). The Australian Guidelines for subsidisation of pharmaceuticals. Pharmacoeconomics, 2, 422–426.PubMedCrossRef
Zurück zum Zitat Jacobs, P., & Baladi, J. F. (1996). Biases in cost measurement for economic evaluation studies in health care. Health Economics, 5, 525–529.PubMedCrossRef Jacobs, P., & Baladi, J. F. (1996). Biases in cost measurement for economic evaluation studies in health care. Health Economics, 5, 525–529.PubMedCrossRef
Zurück zum Zitat Jacobs, P., Bachynsky, J., & Baladi, J. F. (1995). A comparative review of pharmacoeconomic guidelines. Pharmacoeconomics, 8, 182–189.PubMedCrossRef Jacobs, P., Bachynsky, J., & Baladi, J. F. (1995). A comparative review of pharmacoeconomic guidelines. Pharmacoeconomics, 8, 182–189.PubMedCrossRef
Zurück zum Zitat Jacobs, P., Ohinmaa, A., & Brady, B. (2005). Providing systematic guidance in pharmacoeconomic guidelines for analysing costs. Pharmacoeconomics, 23, 143–153.PubMedCrossRef Jacobs, P., Ohinmaa, A., & Brady, B. (2005). Providing systematic guidance in pharmacoeconomic guidelines for analysing costs. Pharmacoeconomics, 23, 143–153.PubMedCrossRef
Zurück zum Zitat Katzmarzyk, P. T., Gledhill, N., & Shephard, R. J. (2000). The economic burden of physical inactivity in Canada. Canadian Medical Association Journal, 163, 1435–1440.PubMed Katzmarzyk, P. T., Gledhill, N., & Shephard, R. J. (2000). The economic burden of physical inactivity in Canada. Canadian Medical Association Journal, 163, 1435–1440.PubMed
Zurück zum Zitat Kirchgassler, K. U. (1990). Health and social inequities in the Federal Republic of Germany. Social Science and Medicine, 31, 249–256.PubMedCrossRef Kirchgassler, K. U. (1990). Health and social inequities in the Federal Republic of Germany. Social Science and Medicine, 31, 249–256.PubMedCrossRef
Zurück zum Zitat Kohlmann, T., Bullinger, M., & Kirchberger-Blumstein, I. (1997). German version of the Nottingham Health Profile (NHP): Translation and psychometric validation [in German]. Sozial- und Praventivmedizin, 42, 175–185.PubMedCrossRef Kohlmann, T., Bullinger, M., & Kirchberger-Blumstein, I. (1997). German version of the Nottingham Health Profile (NHP): Translation and psychometric validation [in German]. Sozial- und Praventivmedizin, 42, 175–185.PubMedCrossRef
Zurück zum Zitat Krauth, C., Hessel, F., Hansmeier, T., Wasem, J., Seitz, R., & Schweikert, B. (2005). Empirical standard costs for health economic evaluation in Germany—a proposal by the working group methods in health economic evaluation [in German]. Gesundheitswesen, 67, 736–746.PubMedCrossRef Krauth, C., Hessel, F., Hansmeier, T., Wasem, J., Seitz, R., & Schweikert, B. (2005). Empirical standard costs for health economic evaluation in Germany—a proposal by the working group methods in health economic evaluation [in German]. Gesundheitswesen, 67, 736–746.PubMedCrossRef
Zurück zum Zitat Lagerros, Y. T., & Lagiou, P. (2007). Assessment of physical activity and energy expenditure in epidemiological research of chronic diseases. European Journal of Epidemiology, 22, 353–362.PubMedCrossRef Lagerros, Y. T., & Lagiou, P. (2007). Assessment of physical activity and energy expenditure in epidemiological research of chronic diseases. European Journal of Epidemiology, 22, 353–362.PubMedCrossRef
Zurück zum Zitat Liljas, B. (1998). How to calculate indirect costs in economic evaluations. Pharmacoeconomics, 13, 1–7.PubMedCrossRef Liljas, B. (1998). How to calculate indirect costs in economic evaluations. Pharmacoeconomics, 13, 1–7.PubMedCrossRef
Zurück zum Zitat Mankiw, N. G., & Taylor, M. P. (2007). Macroeconomics. New York: Worth Publishing. Mankiw, N. G., & Taylor, M. P. (2007). Macroeconomics. New York: Worth Publishing.
Zurück zum Zitat Martinson, B. C., Crain, A. L., Pronk, N. P., O’Connor, P. J., & Maciosek, M. V. (2003). Changes in physical activity and short-term changes in health care charges: A prospective cohort study of older adults. Preventive Medicine, 37, 319–326.PubMedCrossRef Martinson, B. C., Crain, A. L., Pronk, N. P., O’Connor, P. J., & Maciosek, M. V. (2003). Changes in physical activity and short-term changes in health care charges: A prospective cohort study of older adults. Preventive Medicine, 37, 319–326.PubMedCrossRef
Zurück zum Zitat Mason, J. (1997). The generalisability of pharmacoeconomic studies. Pharmacoeconomics, 11, 503–514.PubMedCrossRef Mason, J. (1997). The generalisability of pharmacoeconomic studies. Pharmacoeconomics, 11, 503–514.PubMedCrossRef
Zurück zum Zitat McDowell, I. (2006). Measurement scales—A guide to rating scales and questionnaires. New York: Oxford University Press. McDowell, I. (2006). Measurement scales—A guide to rating scales and questionnaires. New York: Oxford University Press.
Zurück zum Zitat National Institute for Clinical Excellence (NICE). (2004). Guideline development methods: Information for national collaborating centres and guideline developers. London, UK: National Institute for Clinical Excellence. National Institute for Clinical Excellence (NICE). (2004). Guideline development methods: Information for national collaborating centres and guideline developers. London, UK: National Institute for Clinical Excellence.
Zurück zum Zitat Nocon, M., Keil, T., & Willich, S. N. (2007). Education, income, occupational status and health risk behaviour. Journal of Public Health, 15, 401.CrossRef Nocon, M., Keil, T., & Willich, S. N. (2007). Education, income, occupational status and health risk behaviour. Journal of Public Health, 15, 401.CrossRef
Zurück zum Zitat Oostenbrink, J. B., Koopmanschap, M. A., & Rutten, F. F. (2002). Standardisation of costs: The Dutch Manual for Costing in economic evaluations. Pharmacoeconomics, 20, 443–454.PubMedCrossRef Oostenbrink, J. B., Koopmanschap, M. A., & Rutten, F. F. (2002). Standardisation of costs: The Dutch Manual for Costing in economic evaluations. Pharmacoeconomics, 20, 443–454.PubMedCrossRef
Zurück zum Zitat Oostenbrink, J. B., Buijs-Van der Woude, T., van Agthoven, M., Koopmanschap, M. A., & Rutten, F. F. (2003). Unit costs of inpatient hospital days. Pharmacoeconomics, 21, 263–271.PubMedCrossRef Oostenbrink, J. B., Buijs-Van der Woude, T., van Agthoven, M., Koopmanschap, M. A., & Rutten, F. F. (2003). Unit costs of inpatient hospital days. Pharmacoeconomics, 21, 263–271.PubMedCrossRef
Zurück zum Zitat Parkerson, G. R., Jr., Broadhead, W. E., & Tse, C. K. (1990). The Duke Health Profile. A 17-item measure of health and dysfunction. Medical Care, 28, 1056–1072.PubMedCrossRef Parkerson, G. R., Jr., Broadhead, W. E., & Tse, C. K. (1990). The Duke Health Profile. A 17-item measure of health and dysfunction. Medical Care, 28, 1056–1072.PubMedCrossRef
Zurück zum Zitat Philips, Z., Bojke, L., Sculpher, M., Claxton, K., & Golder, S. (2006). Good practice guidelines for decision-analytic modelling in health technology assessment: A review and consolidation of quality assessment. Pharmacoeconomics, 24, 355–371.PubMedCrossRef Philips, Z., Bojke, L., Sculpher, M., Claxton, K., & Golder, S. (2006). Good practice guidelines for decision-analytic modelling in health technology assessment: A review and consolidation of quality assessment. Pharmacoeconomics, 24, 355–371.PubMedCrossRef
Zurück zum Zitat Plotnikoff, R. C., Mayhew, A., Birkett, N., Loucaides, C. A., & Fodor, G. (2004). Age, gender, and urban-rural differences in the correlates of physical activity. Preventive Medicine, 39, 1115–1125.PubMedCrossRef Plotnikoff, R. C., Mayhew, A., Birkett, N., Loucaides, C. A., & Fodor, G. (2004). Age, gender, and urban-rural differences in the correlates of physical activity. Preventive Medicine, 39, 1115–1125.PubMedCrossRef
Zurück zum Zitat Racioppi, F., Dora, C., Krech, R., & von Ehrenstein, O. (2002). A physically active life through everyday transport. With a special focus on children and older people and examples and approaches from Europe. Copenhagen, Denmark: World Health Organization (WHO) Regional Office for Europe. Racioppi, F., Dora, C., Krech, R., & von Ehrenstein, O. (2002). A physically active life through everyday transport. With a special focus on children and older people and examples and approaches from Europe. Copenhagen, Denmark: World Health Organization (WHO) Regional Office for Europe.
Zurück zum Zitat Robinson, A., Loomes, G., & Jones-Lee, M. (2001). Visual analog scales, standard gambles, and relative risk aversion. Medical Decision Making, 21, 17–27.PubMedCrossRef Robinson, A., Loomes, G., & Jones-Lee, M. (2001). Visual analog scales, standard gambles, and relative risk aversion. Medical Decision Making, 21, 17–27.PubMedCrossRef
Zurück zum Zitat Russell, L. B., Gold, M. R., Siegel, J. E., Daniels, N., & Weinstein, M. C. (1996). The role of cost-effectiveness analysis in health and medicine. Panel on cost-effectiveness in health and medicine. The Journal of the American Medical Association, 276, 1172–1177.CrossRef Russell, L. B., Gold, M. R., Siegel, J. E., Daniels, N., & Weinstein, M. C. (1996). The role of cost-effectiveness analysis in health and medicine. Panel on cost-effectiveness in health and medicine. The Journal of the American Medical Association, 276, 1172–1177.CrossRef
Zurück zum Zitat Rutten, F. (1996). Economic evaluation and health care decision-making. Health Policy, 36, 215–229.PubMedCrossRef Rutten, F. (1996). Economic evaluation and health care decision-making. Health Policy, 36, 215–229.PubMedCrossRef
Zurück zum Zitat Sallis, J. F., & Owen, N. (1998). Physical activity and behavioral medicine. Thousand Oaks, CA: Sage. Sallis, J. F., & Owen, N. (1998). Physical activity and behavioral medicine. Thousand Oaks, CA: Sage.
Zurück zum Zitat Schulz, O., & Dursch, M. (2003). From bench to bicycle. Risk assessment in connection with sports activities and exercise programs in the primary and secondary prevention of cardiovascular diseases [in German]. Herz, 28, 359–373.PubMedCrossRef Schulz, O., & Dursch, M. (2003). From bench to bicycle. Risk assessment in connection with sports activities and exercise programs in the primary and secondary prevention of cardiovascular diseases [in German]. Herz, 28, 359–373.PubMedCrossRef
Zurück zum Zitat Scott, K. M., Sarfati, D., Tobias, M. I., & Haslett, S. J. (2000). A challenge to the cross-cultural validity of the SF-36 health survey: Factor structure in Maori, Pacific and New Zealand European ethnic groups. Social Science and Medicine, 51, 1655–1664.PubMedCrossRef Scott, K. M., Sarfati, D., Tobias, M. I., & Haslett, S. J. (2000). A challenge to the cross-cultural validity of the SF-36 health survey: Factor structure in Maori, Pacific and New Zealand European ethnic groups. Social Science and Medicine, 51, 1655–1664.PubMedCrossRef
Zurück zum Zitat Sculpher, M. J., Pang, F. S., Manca, A., Drummond, M. F., Golder, S., Urdahl, H., et al. (2004). Generalisability in economic evaluation studies in healthcare: A review and case studies. Health Technology Assessment, 8, iii–iv, 1–192. Sculpher, M. J., Pang, F. S., Manca, A., Drummond, M. F., Golder, S., Urdahl, H., et al. (2004). Generalisability in economic evaluation studies in healthcare: A review and case studies. Health Technology Assessment, 8, iii–iv, 1–192.
Zurück zum Zitat Siegel, J. E., Weinstein, M. C., Russell, L. B., & Gold, M. R. (1996). Recommendations for reporting cost-effectiveness analyses. Panel on cost-effectiveness in health and medicine. The Journal of the American Medical Association, 276, 1339–1341.CrossRef Siegel, J. E., Weinstein, M. C., Russell, L. B., & Gold, M. R. (1996). Recommendations for reporting cost-effectiveness analyses. Panel on cost-effectiveness in health and medicine. The Journal of the American Medical Association, 276, 1339–1341.CrossRef
Zurück zum Zitat Siegel, J. E., Torrance, G. W., Russell, L. B., Luce, B. R., Weinstein, M. C., & Gold, M. R. (1997). Guidelines for pharmacoeconomic studies. Recommendations from the panel on cost effectiveness in health and medicine. Panel on Cost Effectiveness in Health and Medicine. Pharmacoeconomics, 11, 159–168.PubMedCrossRef Siegel, J. E., Torrance, G. W., Russell, L. B., Luce, B. R., Weinstein, M. C., & Gold, M. R. (1997). Guidelines for pharmacoeconomic studies. Recommendations from the panel on cost effectiveness in health and medicine. Panel on Cost Effectiveness in Health and Medicine. Pharmacoeconomics, 11, 159–168.PubMedCrossRef
Zurück zum Zitat Siebert, U. (2005). Entscheidungsanalytische Modelle zur Sicherung der Übertragbarkeit internationaler Evidenz von HTA auf den Kontext des deutschen Gesundheitssystems, Ein Methodenbeitrag zum HTA. (Health Technology Assessment). Cologne, Germany: DAHTA/DIMDI. Siebert, U. (2005). Entscheidungsanalytische Modelle zur Sicherung der Übertragbarkeit internationaler Evidenz von HTA auf den Kontext des deutschen Gesundheitssystems, Ein Methodenbeitrag zum HTA. (Health Technology Assessment). Cologne, Germany: DAHTA/DIMDI.
Zurück zum Zitat Smith, D. H., & Gravelle, H. (2001). The practice of discounting in economic evaluations of healthcare interventions. International Journal of Technology Assessment in Health Care, 17, 236–243.PubMedCrossRef Smith, D. H., & Gravelle, H. (2001). The practice of discounting in economic evaluations of healthcare interventions. International Journal of Technology Assessment in Health Care, 17, 236–243.PubMedCrossRef
Zurück zum Zitat Swiss Federal Office of Sports. (2001). Economic benefits of the health enhancing effects of physical activity: First estimates for Switzerland [in German]. Schweizerische Zeitschrift für Sportmedizin und Sporttraumatologie, 49, 131–133. Swiss Federal Office of Sports. (2001). Economic benefits of the health enhancing effects of physical activity: First estimates for Switzerland [in German]. Schweizerische Zeitschrift für Sportmedizin und Sporttraumatologie, 49, 131–133.
Zurück zum Zitat Tucker, P., & Gilliland, J. (2007). The effect of season and weather on physical activity: A systematic review. Public Health, 121, 909–922.PubMedCrossRef Tucker, P., & Gilliland, J. (2007). The effect of season and weather on physical activity: A systematic review. Public Health, 121, 909–922.PubMedCrossRef
Zurück zum Zitat von Lengerke, T., Wolfenstetter, S. B., & John, J. (2008). Obesity associated utilization of health care in Germany [in German]. In A. Hilbert & P. Dabrock (Eds.), Weighted Genes: Obesity between predisposition and self-responsibility [Gewichtige Gene: Adipositas zwischen Prädisposition und Eigenverantwortung]. Bern, Switzerland: Huber. von Lengerke, T., Wolfenstetter, S. B., & John, J. (2008). Obesity associated utilization of health care in Germany [in German]. In A. Hilbert & P. Dabrock (Eds.), Weighted Genes: Obesity between predisposition and self-responsibility [Gewichtige Gene: Adipositas zwischen Prädisposition und Eigenverantwortung]. Bern, Switzerland: Huber.
Zurück zum Zitat Ware, J. E., Jr., Kosinski, M., Gandek, B., Aaronson, N. K., Apolone, G., Bech, P., et al. (1998). The factor structure of the SF-36 Health Survey in 10 countries: results from the IQOLA Project. International Quality of Life Assessment. Journal of Clinical Epidemiology, 51, 1159–1165.PubMedCrossRef Ware, J. E., Jr., Kosinski, M., Gandek, B., Aaronson, N. K., Apolone, G., Bech, P., et al. (1998). The factor structure of the SF-36 Health Survey in 10 countries: results from the IQOLA Project. International Quality of Life Assessment. Journal of Clinical Epidemiology, 51, 1159–1165.PubMedCrossRef
Zurück zum Zitat Weinstein, M. C., Siegel, J. E., Gold, M. R., Kamlet, M. S., & Russell, L. B. (1996). Recommendations of the panel on cost-effectiveness in health and medicine. The Journal of the American Medical Association, 276, 1253–1258.CrossRef Weinstein, M. C., Siegel, J. E., Gold, M. R., Kamlet, M. S., & Russell, L. B. (1996). Recommendations of the panel on cost-effectiveness in health and medicine. The Journal of the American Medical Association, 276, 1253–1258.CrossRef
Zurück zum Zitat Welte, R., Feenstra, T., Jager, H., & Leidl, R. (2004). A decision chart for assessing and improving the transferability of economic evaluation results between countries. Pharmacoeconomics, 22, 857–876.PubMedCrossRef Welte, R., Feenstra, T., Jager, H., & Leidl, R. (2004). A decision chart for assessing and improving the transferability of economic evaluation results between countries. Pharmacoeconomics, 22, 857–876.PubMedCrossRef
Zurück zum Zitat Whitaker, M. J. (1998). Consensus guidelines for evaluating and treating patients with upper gastrointestinal symptoms in the primary care setting. Pharmacoeconomics, 14, 5–10.PubMedCrossRef Whitaker, M. J. (1998). Consensus guidelines for evaluating and treating patients with upper gastrointestinal symptoms in the primary care setting. Pharmacoeconomics, 14, 5–10.PubMedCrossRef
Zurück zum Zitat World Health Organization (WHO). (2005). European Health Report: Public health action for healthier children and populations. Copenhagen: Author. World Health Organization (WHO). (2005). European Health Report: Public health action for healthier children and populations. Copenhagen: Author.
Metadaten
Titel
Conceptual Framework for Standard Economic Evaluation of Physical Activity Programs in Primary Prevention
verfasst von
Silke B. Wolfenstetter
Publikationsdatum
01.12.2011
Verlag
Springer US
Erschienen in
Prevention Science / Ausgabe 4/2011
Print ISSN: 1389-4986
Elektronische ISSN: 1573-6695
DOI
https://doi.org/10.1007/s11121-011-0235-4

Weitere Artikel der Ausgabe 4/2011

Prevention Science 4/2011 Zur Ausgabe